CN101756909B - 肺靶向头孢噻呋微球及制备方法 - Google Patents
肺靶向头孢噻呋微球及制备方法 Download PDFInfo
- Publication number
- CN101756909B CN101756909B CN2010101266663A CN201010126666A CN101756909B CN 101756909 B CN101756909 B CN 101756909B CN 2010101266663 A CN2010101266663 A CN 2010101266663A CN 201010126666 A CN201010126666 A CN 201010126666A CN 101756909 B CN101756909 B CN 101756909B
- Authority
- CN
- China
- Prior art keywords
- microsphere
- ceftiofur
- lung
- targeting
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 65
- ZBHXIWJRIFEVQY-IHMPYVIRSA-N ceftiofur Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC(=O)C1=CC=CO1 ZBHXIWJRIFEVQY-IHMPYVIRSA-N 0.000 title claims abstract description 46
- 229960005229 ceftiofur Drugs 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000012876 carrier material Substances 0.000 claims abstract description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 27
- 239000004626 polylactic acid Substances 0.000 claims description 26
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 19
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 19
- 239000002245 particle Substances 0.000 claims description 13
- 239000004698 Polyethylene Substances 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- -1 polyethylene Polymers 0.000 claims description 12
- 229920000573 polyethylene Polymers 0.000 claims description 12
- 208000035126 Facies Diseases 0.000 claims description 10
- 230000001804 emulsifying effect Effects 0.000 claims description 9
- 238000000227 grinding Methods 0.000 claims description 9
- 239000000523 sample Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 50
- 230000000694 effects Effects 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 16
- 210000004072 lung Anatomy 0.000 abstract description 7
- 241001465754 Metazoa Species 0.000 abstract description 6
- 238000011068 loading method Methods 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000004945 emulsification Methods 0.000 abstract description 3
- 238000009826 distribution Methods 0.000 abstract description 2
- 244000144977 poultry Species 0.000 abstract description 2
- 206010059866 Drug resistance Diseases 0.000 abstract 1
- 208000032376 Lung infection Diseases 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 17
- 239000007864 aqueous solution Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 238000004090 dissolution Methods 0.000 description 9
- 230000002685 pulmonary effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 230000008685 targeting Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical group O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 230000000680 avirulence Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- RFLHUYUQCKHUKS-JUODUXDSSA-M Ceftiofur sodium Chemical compound [Na+].S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC(=O)C1=CC=CO1 RFLHUYUQCKHUKS-JUODUXDSSA-M 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229960004467 ceftiofur sodium Drugs 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000001132 ultrasonic dispersion Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101266663A CN101756909B (zh) | 2010-03-18 | 2010-03-18 | 肺靶向头孢噻呋微球及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101266663A CN101756909B (zh) | 2010-03-18 | 2010-03-18 | 肺靶向头孢噻呋微球及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101756909A CN101756909A (zh) | 2010-06-30 |
CN101756909B true CN101756909B (zh) | 2012-09-05 |
Family
ID=42488395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101266663A Expired - Fee Related CN101756909B (zh) | 2010-03-18 | 2010-03-18 | 肺靶向头孢噻呋微球及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101756909B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CL2011002901A1 (es) * | 2011-11-18 | 2012-07-06 | Univ Santiago Chile | Composicion veterinaria inyectable de liberacion prolongada y dosis unica que comprende microparticulas de polihidroxibutirato co-3-hidroxivalerato (phbv), un agente antimicrobiano seleccionado de ceftiofur o florfenicol y agua para inyeccion; procedimiento de preparacion; util para tratar infecciones en animales. |
CN107320452B (zh) * | 2017-07-07 | 2020-04-28 | 青岛农业大学 | 一种肺靶向硫酸头孢喹诺ec微球及其制备方法 |
CN108125957A (zh) * | 2017-12-22 | 2018-06-08 | 天津国际生物医药联合研究院 | 头孢噻呋盐酸盐在抗结核分枝杆菌感染中的应用 |
CN112353765B (zh) * | 2020-11-09 | 2022-05-31 | 山东华辰制药有限公司 | 一种头孢噻呋微球的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1415295A (zh) * | 2002-08-08 | 2003-05-07 | 广东药学院 | 一种环丙沙星聚乳酸微球的制备方法 |
CN101283971A (zh) * | 2006-05-17 | 2008-10-15 | 济南帅华医药科技有限公司 | 一种含抗生素林可霉素的缓释注射剂及其应用 |
-
2010
- 2010-03-18 CN CN2010101266663A patent/CN101756909B/zh not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
冯立等.肺靶向微粒的研究概况.《药学专论》.2006,第15卷(第12期),1-2. * |
刘蜀宝等.第十八章 靶向制剂.《药学高职高专系列教材药剂学》.河南科学技术出版社,2007,463. * |
张万国等.肺靶向利福平聚乳酸微球的研究.《药学学报》.1998,第33卷(第1期),57-61. * |
Also Published As
Publication number | Publication date |
---|---|
CN101756909A (zh) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101756910B (zh) | 一种肺靶向头孢噻呋微球及制备方法 | |
CN101623256B (zh) | 一种伊维菌素纳米乳药物组合物及其制备方法 | |
CN103205863B (zh) | 一种细菌纤维素缓释敷料的制备方法 | |
CN101756909B (zh) | 肺靶向头孢噻呋微球及制备方法 | |
CN101250764A (zh) | 一种纳米载药聚丙烯腈纤维、制备及应用 | |
CN103550816A (zh) | 一种壳聚糖基静电纺丝复合伤口敷料的制备方法 | |
CN101773478B (zh) | 一种兽用头孢噻呋盐酸盐的肺靶向微球及制备方法 | |
CN102188756A (zh) | 一种含药缓释降解骨支架的制备方法 | |
CN107773554A (zh) | 一种伊维菌素缓释微囊及其制备方法和应用 | |
CN105582019A (zh) | 一种替米考星固体分散剂及其制备方法 | |
CN100428957C (zh) | 一种纤维状磁性药物及其制备方法 | |
CN103191422A (zh) | 一种用于养殖海水鱼类三联口服疫苗及制备和使用方法 | |
CN102283842A (zh) | 一种复方乙酰甲喹氟苯尼考纳米乳抗菌药物及其制备方法 | |
CN100560133C (zh) | 磁性聚乳酸-羟基乙酸氧化酚砷纳米微球及其制药用途 | |
CN101536985A (zh) | 一种畜禽使用的头孢喹肟肺靶向微球及其制备方法 | |
CN101874774A (zh) | 一种含有溶菌酶和氟苯尼考的混悬剂组合物及其制备方法 | |
CN110693814A (zh) | 一种兽用替米考星纳米凝胶乳房灌注剂及其制备方法 | |
CN106176613B (zh) | 一种兽用缓释硫氰酸红霉素可溶性粉及其制备方法 | |
CN104337797B (zh) | 一种多药集成型复合载药纤维膜的制备方法 | |
CN101773477B (zh) | 一种畜禽用头孢噻呋的肺靶向微球及制备方法 | |
CN101829063B (zh) | 兽用头孢噻呋盐酸盐的肺靶向微球及制备方法 | |
CN105232465A (zh) | 一种芬苯达唑脂质体制剂及其制备方法 | |
CN117224670B (zh) | 一种脂质体佐剂组合物、疫苗组合物及其制备方法和应用 | |
CN105311631A (zh) | CaP-PLA/PLGA纳微球及其制备方法与应用 | |
CN102526110B (zh) | 一种用于强心急救的蟾酥粉末注射剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO KDN ANIMAL PHARMACEUTICAL CO., LTD. QINGDA Free format text: FORMER OWNER: QINGDAO LIUHE MEDICINE CO., LTD. Effective date: 20120525 Owner name: QINGDAO KDN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: QINGDAO CONTINENT BIOTECH CO., LTD. Effective date: 20120525 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120525 Address after: 266061 Shandong city of Qingdao province high tech park of Laoshan district by the No. 29 Shandong Road, building 605 high speed Applicant after: QINGDAO KDN PHARMACEUTICAL Co.,Ltd. Co-applicant after: QINGDAO KDN BIOTECH Co.,Ltd. Co-applicant after: Qingdao Agricultural University Address before: 266061 Shandong city of Qingdao province high tech park of Laoshan district by the No. 29 Shandong Road, building 605 high speed Applicant before: Qingdao Vland Biotech INC. Co-applicant before: Qingdao Liuhe Pharmaceuticals Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: QINGDAO WEILAN BIOLOGY CO., LTD. Free format text: FORMER NAME: QINGDAO KDN PHARMACEUTICAL CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 266061 Shandong city of Qingdao province Chengyang Qingda Industrial Park, the first northbound dual Patentee after: QINGDAO VLAND BIOTECH Inc. Patentee after: QINGDAO KDN BIOTECH Co.,Ltd. Patentee after: Qingdao Agricultural University Address before: 266061 Shandong city of Qingdao province high tech park of Laoshan district by the No. 29 Shandong Road, building 605 high speed Patentee before: QINGDAO KDN PHARMACEUTICAL Co.,Ltd. Patentee before: QINGDAO KDN BIOTECH Co.,Ltd. Patentee before: Qingdao Agricultural University |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120905 |